PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPeptic esophagitis
MeSH D004942 - peptic esophagitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004941:Esophagitis
85 Companies
11 Drugs
$
Success rate
D010437:Peptic ulcer
76 Companies
13 Drugs
$
Success rate
D004942: 
Peptic esophagitis
75 Companies
7 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieFamotidine Famotidine  2001-12-17   
Ajanta PharmaRanitidine Ranitidine  2018-09-27   
Famotidine Famotidine  2023-09-18   
AkornFamotidine Famotidine  2014-05-30   
Alembic PharmaceuticalsFamotidine Famotidine  2009-05-22   
Alkem LaboratoriesFamotidine, Ibuprofen Ibuprofen Famotidine  2021-08-03   
Famotidine Famotidine  2022-01-07   
AllerganFamotidine Famotidine  2001-04-16   
Nizatidine Nizatidine  2002-07-09   
Ranitidine Ranitidine  1997-10-20   
Amneal PharmaceuticalsFamotidine Famotidine  2022-08-04   
Nizatidine Nizatidine  2009-11-18   
Ranitidine Ranitidine  2006-10-13 $8.678 M Y2017 
ANI PharmaceuticalsNizatidine Nizatidine  2002-07-08   
Ranitidine Ranitidine  1997-07-31   
Annora PharmaFamotidine Famotidine  2021-11-08   
ApotexFamotidine Famotidine  2002-03-12   
Nizatidine Nizatidine  2003-01-23   
Ranitidine Ranitidine  1997-09-12   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
50%
1/2
Phase 2
86%
6/7
Phase 3
85%
11/13
Approved: 6Overall Success rate: 36%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bausch Health Companies
Nahco3,
Antacid
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use